Skip to content
Unrated Drug recall · FDA · Published July 20, 2015

Qualitest Recalls Allopurinol Tablets Due to Defects

Qualitest Pharmaceuticals recalls 21,552 units of Allopurinol Tablets USP 300 mg due to oversized and discolored tablets. Check your bottle.

🇺🇸 FDA recall #D-1405-2015DrugQualitest Pharmaceuticals ›
Take action

Contact the company

Recalling firmQualitest Pharmaceuticals120 Vintage Dr NE · Huntsville, AL 35811-8216
✎ GovInfoNow plain-language explainer

Qualitest Pharmaceuticals is recalling Allopurinol Tablets USP, 300 mg, in 500-count bottles because the tablets failed specification tests. The issue involves reports of tablets being oversized and discolored. This recall affects units distributed nationwide and in Puerto Rico. Read more at govinfonow.com/recall/44007-qualitest-pharmaceuticals-recalls-allopurinol-tablets-usp-300-mg-500-count.

Source Summary by GovInfoNow · govinfonow.com/recall/44007-qualitest-pharmaceuticals-recalls-allopurinol-tablets-usp-300-mg-500-count · Updated October 12, 2026 · FDA enforcement record: FDA #D-1405-2015

Cite this page

“Qualitest Recalls Allopurinol Tablets Due to Defects.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/44007-qualitest-pharmaceuticals-recalls-allopurinol-tablets-usp-300-mg-500-count. Based on FDA recall #D-1405-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1405-2015%22&limit=1).

The FDA announced on July 20, 2015, that Qualitest Pharmaceuticals voluntarily recalled Allopurinol Tablets USP 300 mg due to failed tablet specifications involving oversized and discolored tablets. The recall affects 21,552 units distributed nationwide and in Puerto Rico.

How to tell if you have it

  • Brand: Qualitest Pharmaceuticals
  • Product: Allopurinol Tablets USP 300 mg
  • NDC: 0603-2116-28
  • Lot code: CP0761501
  • Expiration date: 12/16

The hazard

The tablets failed specifications for size and appearance, with reports of oversized and discolored tablets. The FDA classified this as a Class III recall.

Context

GovInfoNow's records show Qualitest Pharmaceuticals has 12 other recalls on record since April 19, 2013. Other recent recalls include Hydroxyzine Tablets due to unreadable codes on June 29, 2015, Disulfiram 500mg Tablets due to dissolution failure on June 18, 2015, and Promethazine VC with Codeine Syrup due to impurity issues on March 25, 2015. Other recent recalls of similar products include Shoolin Pharma Chem Sildenafil Recall: FDA Inspection Findings (August 3, 2026), Golden State Medical Recalls Prasugrel HCl 10mg Tablets (August 21, 2026), and Inventia Chlorthalidone Recall: Failed Dissolution Specs (September 3, 2026).

How to tell if you have this one

Check if you have Allopurinol Tablets USP, 300 mg, in a 500-count bottle. Look for NDC 0603-2116-28 and Lot Number CP0761501 with an expiration date of 12/16. The product was manufactured for Qualitest Pharmaceuticals in Huntsville, AL.

  • Brand
    Qualitest Pharmaceuticals
  • Category
    Drug

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide and PR” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 8 months after the firm started it.

1. Firm started the recall: Jul 20, 201512. FDA classified it Class III: Sep 1, 201523. Published in FDA’s Enforcement Report: Sep 9, 201534. FDA terminated the recall: Mar 7, 2016420152016
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1405-2015 (July 20, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1405-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA